NZ184141A - Pharmaceutical tablet formulation containing anti-allergic drug - Google Patents

Pharmaceutical tablet formulation containing anti-allergic drug

Info

Publication number
NZ184141A
NZ184141A NZ184141A NZ18414177A NZ184141A NZ 184141 A NZ184141 A NZ 184141A NZ 184141 A NZ184141 A NZ 184141A NZ 18414177 A NZ18414177 A NZ 18414177A NZ 184141 A NZ184141 A NZ 184141A
Authority
NZ
New Zealand
Prior art keywords
formulation containing
tablet formulation
containing anti
pharmaceutical tablet
allergic drug
Prior art date
Application number
NZ184141A
Other languages
English (en)
Inventor
Aw Jenkins
Tj Sullivan
Jnc Healey
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NZ184141A publication Critical patent/NZ184141A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ184141A 1976-05-21 1977-05-18 Pharmaceutical tablet formulation containing anti-allergic drug NZ184141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20984/76A GB1570993A (en) 1976-05-21 1976-05-21 Pharmaceutical tablet formulation

Publications (1)

Publication Number Publication Date
NZ184141A true NZ184141A (en) 1979-06-19

Family

ID=10155196

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184141A NZ184141A (en) 1976-05-21 1977-05-18 Pharmaceutical tablet formulation containing anti-allergic drug

Country Status (17)

Country Link
JP (1) JPS52143220A (de)
AU (1) AU511269B2 (de)
BE (1) BE854690A (de)
CA (1) CA1105835A (de)
DE (1) DE2722917A1 (de)
DK (1) DK218777A (de)
FI (1) FI771587A (de)
FR (1) FR2426460A1 (de)
GB (1) GB1570993A (de)
IE (1) IE45282B1 (de)
IL (1) IL52102A0 (de)
LU (1) LU77369A1 (de)
NL (1) NL7705560A (de)
NO (1) NO771765L (de)
NZ (1) NZ184141A (de)
SE (1) SE7705850L (de)
ZA (1) ZA772989B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595220A (en) * 1977-12-23 1981-08-12 Fisons Ltd Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
MXPA03009391A (es) 2001-05-01 2004-01-29 Pfizer Prod Inc METODO PARA FABRICAR UNA COMPOSICIoN FARMACEUTICA DE DOSIS BAJA.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753210B (en) * 1974-06-14 1976-04-28 Upjohn Co Novel dosing regimen for intal biologues
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones
FR2292468A1 (fr) * 1974-11-30 1976-06-25 Fisons Ltd Monochromes

Also Published As

Publication number Publication date
GB1570993A (en) 1980-07-09
FI771587A (de) 1977-11-22
IE45282L (en) 1977-11-21
DE2722917A1 (de) 1977-12-01
FR2426460A1 (fr) 1979-12-21
AU511269B2 (en) 1980-08-07
LU77369A1 (de) 1977-12-13
CA1105835A (en) 1981-07-28
DK218777A (da) 1977-11-22
BE854690A (fr) 1977-11-16
SE7705850L (sv) 1977-11-22
JPS52143220A (en) 1977-11-29
IE45282B1 (en) 1982-07-28
FR2426460B1 (de) 1983-04-29
NO771765L (no) 1977-11-22
AU2521477A (en) 1978-11-23
ZA772989B (en) 1978-04-26
NL7705560A (nl) 1977-11-23
IL52102A0 (en) 1977-07-31

Similar Documents

Publication Publication Date Title
AU513845B2 (en) Pharmaceutical dosage forms
JPS567714A (en) Pharmaceutical medicine
IL51660A (en) Hentriakontapetides being -endorphins their preparation and pharmaceutical compostions containing them
AU499873B2 (en) Microsealed pharmaceutical delivery device
ZA795530B (en) Pharmaceutical tablet for oral administration and process for its manufacture
JPS55147223A (en) Pharmaceutical medicine
IL51096A0 (en) Novel pharmaceutical dosage form
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
JPS5264420A (en) Medicine releasing controled tablet and its preparation
JPS5618982A (en) Pyrimidine derivatives and medicinal drug containing them
AU504182B2 (en) Pharmaceutical dosage forms
PH11669A (en) Thienobenzo(1,5)diazepine derivatives and the pharmaceutical formulation thereof
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
JPS52105186A (en) Piperazine derivative and its preparation and medicine containing same
JPS5369822A (en) Pharmaceutical agent
IL46682A (en) Pharmaceutical capsules containing difoxin
AU1306576A (en) Pharmaceutical formulation
JPS52128357A (en) Antiitumor drug
NZ184141A (en) Pharmaceutical tablet formulation containing anti-allergic drug
ZA76829B (en) Tablet formulation
JPS52128364A (en) Novel corticoid * preparation thereof and antiiinflamatory pharmaceutical agent containing the same
GB1547562A (en) Guns eg for use in the administration of drugs or medicines to animals
AU3149277A (en) D-homosteroids and pharmaceutical preparation
JPS5283919A (en) Pharmaceutical tablet
JPS5338620A (en) Isomalin antiimold drug